| scholarly article | Q13442814 |
| P50 | author | Lewis Kuller | Q88077314 |
| Alice M. Arnold | Q124357286 | ||
| Bruce M. Psaty | Q30429993 | ||
| P2093 | author name string | Russell P Tracy | |
| Nancy Swords Jenny | |||
| P2860 | cites work | Inflammation biomarkers and near-term death in older men. | Q53581064 |
| Serum amyloid P and cardiovascular disease in older men and women: results from the Cardiovascular Health Study. | Q53583734 | ||
| Establishment of a High Sensitivity Plasma Assay for Human Pentraxin3 as a Marker for Unstable Angina Pectoris | Q56942761 | ||
| Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study | Q70785076 | ||
| Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study | Q72533170 | ||
| Laboratory methods and quality assurance in the Cardiovascular Health Study | Q72588345 | ||
| The Cardiovascular Health Study: design and rationale | Q29614874 | ||
| Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus | Q29616284 | ||
| Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? | Q33829116 | ||
| PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans | Q33912738 | ||
| PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation | Q34106947 | ||
| Long pentraxin PTX3 upregulates tissue factor expression in human endothelial cells: a novel link between vascular inflammation and clotting activation | Q34128052 | ||
| Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response | Q34159058 | ||
| Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction | Q34357988 | ||
| The long pentraxin PTX3 in vascular pathology | Q36615475 | ||
| The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein | Q40738906 | ||
| Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality | Q44571381 | ||
| C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: the Cardiovascular Health Study | Q46128170 | ||
| The long pentraxin PTX3 up-regulates tissue factor in activated monocytes: another link between inflammation and clotting activation | Q47265306 | ||
| Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications. | Q50981261 | ||
| Robust variance estimation for the case-cohort design. | Q52364585 | ||
| Calorie restriction modulates inactivity-induced changes in the inflammatory markers C-reactive protein and pentraxin-3. | Q53476226 | ||
| Expression of pentraxin 3 (PTX3) in human atherosclerotic lesions. | Q53502969 | ||
| Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure. | Q53510759 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cardiovascular disease | Q389735 |
| P304 | page(s) | 594-599 | |
| P577 | publication date | 2009-01-22 | |
| P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
| P1476 | title | Associations of pentraxin 3 with cardiovascular disease and all-cause death: the Cardiovascular Health Study | |
| P478 | volume | 29 |
| Q88634530 | Aerobic fitness alters the capacity of mononuclear cells to produce pentraxin 3 following maximal exercise |
| Q55257343 | Association between Plasma Pentraxin 3 Levels and Bone Mineral Density in Elderly Koreans: the Dong-gu Study. |
| Q36533057 | Association between levels of pentraxin 3 and incidence of chronic kidney disease in the elderly |
| Q88779694 | Association of plasma pentraxin-3 levels with coronary risk factors and the lipid profile: a cross-sectional study in Japanese patients with stable angina pectoris |
| Q33748025 | Associations of pentraxin 3 with cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis |
| Q34150807 | Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study |
| Q38472979 | Biological actions of pentraxins |
| Q47813656 | C-Reactive Protein Binds to Cholesterol Crystals and Co-Localizes with the Terminal Complement Complex in Human Atherosclerotic Plaques |
| Q37980497 | Cardiovascular metabolic syndrome: mediators involved in the pathophysiology from obesity to coronary heart disease |
| Q42407067 | Cigarette smoke induces PTX3 expression in pulmonary veins of mice in an IL-1 dependent manner |
| Q55223194 | Circulating pentraxin 3 is positively associated with chronic hyperglycemia but negatively associated with plasma aldosterone concentration. |
| Q89834282 | Combining Novel Biomarkers for Risk Stratification of Two-Year Cardiovascular Mortality in Patients with ST-Elevation Myocardial Infarction |
| Q33593925 | Differential associations of inflammatory and endothelial biomarkers with disease activity in rheumatoid arthritis of short duration |
| Q35109551 | Differential associations of serum amyloid A and pentraxin-3 with allele-specific lipoprotein(a) levels in African Americans and Caucasians |
| Q38380295 | Effects of 6 months of resveratrol versus placebo on pentraxin 3 in patients with type 2 diabetes mellitus: a double-blind randomized controlled trial |
| Q97526121 | Elevated Levels of Pentraxin 3 Correlate With Neutrophilia and Coronary Artery Dilation During Acute Kawasaki Disease |
| Q34551919 | Elevated plasma pentraxin 3 and its association with retinal vein occlusion |
| Q37115819 | Emerging families of biomarkers for coronary artery disease: inflammatory mediators |
| Q92671887 | Estimation of apolipoprotein A in early onset ST-segment elevation myocardial infarction |
| Q82037808 | Hospital mortality of patients with severe traumatic brain injury is associated with serum PTX3 levels |
| Q53081569 | Implications of pentraxin 3 levels in patients with acute aortic dissection. |
| Q43539555 | Inflammatory markers of cardiovascular disease risk in Portuguese psoriatic patients: relation with narrow-band ultraviolet B and psoralen plus ultraviolet A. |
| Q34534979 | Influence of pentraxin 3 (PTX3) genetic variants on myocardial infarction risk and PTX3 plasma levels |
| Q37629231 | Interesting Correlation Between the Circulating Pentraxin 3 and Cardiac Rehabilitation Program Outcomes in Coronary Artery Bypass Grafting Patients |
| Q89687402 | Is pentraxin 3 level an effective biomarker in disease activity in patients with rheumatoid arthritis? |
| Q37019061 | Lifestyle intervention is associated with decreased concentrations of circulating pentraxin 3 independent of CRP decrease. |
| Q87403684 | Lipoprotein(a) levels predict adverse vascular events after acute myocardial infarction |
| Q36830914 | Long pentraxin 3: experimental and clinical relevance in cardiovascular diseases |
| Q102152421 | Macrophage expression and prognostic significance of the long pentraxin PTX3 in COVID-19 |
| Q37160916 | Modification of the secretion pattern of proteases, inflammatory mediators, and extracellular matrix proteins by human aortic valve is key in severe aortic stenosis |
| Q82984348 | PTX3 is located at the membrane of late apoptotic macrophages and mediates the phagocytosis of macrophages |
| Q50143105 | PTX3, a Humoral Pattern Recognition Molecule, in Innate Immunity, Tissue Repair, and Cancer |
| Q57417409 | Pentraxin 3 (PTX3) is associated with cardiovascular risk factors: the Health 2000 Survey |
| Q38728491 | Pentraxin 3 and lipid profile status in pregnancy |
| Q37155352 | Pentraxin 3 as a Novel Marker in Cardiovascular Diseases? |
| Q64105040 | Pentraxin 3 in Cardiovascular Disease |
| Q50533824 | Pentraxin 3 in serum and synovial fluid of patients with rheumatoid arthritis with and without autoantibodies. |
| Q84682599 | Pentraxin 3 increase is much less pronounced than C-reactive protein increase after surgical procedures |
| Q35021428 | Pentraxin 3 mediates neurogenesis and angiogenesis after cerebral ischaemia. |
| Q35915482 | Pentraxin 3(PTX 3): an endogenous modulator of the inflammatory response |
| Q41907221 | Pentraxin 3, ficolin-2 and lectin pathway associated serine protease MASP-3 as early predictors of myocardial infarction - the HUNT2 study. |
| Q33805985 | Pentraxin-3 and the right ventricle: the Multi-Ethnic Study of Atherosclerosis-Right Ventricle Study |
| Q34154838 | Pentraxin-3 as a marker of advanced atherosclerosis results from the Bruneck, ARMY and ARFY Studies |
| Q35924554 | Pentraxin-3 as a marker of disease severity and risk of death in patients with necrotizing soft tissue infections: a nationwide, prospective, observational study. |
| Q48458509 | Pentraxin-3 in chronic heart failure: the CORONA and GISSI-HF trials |
| Q91874565 | Pentraxin-3 is a candidate biomarker on the spectrum of severity from pre-eclampsia to HELLP syndrome: GenPE study |
| Q38991073 | Pentraxins in the activation and regulation of innate immunity |
| Q43142703 | Plasma Pentraxin 3, but not high-sensitivity C-reactive protein, is a useful inflammatory biomarker for predicting cognitive impairment in elderly hypertensive patients |
| Q44456570 | Plasma pentraxin 3 is associated with cardiovascular disease in hemodialysis patients |
| Q35140370 | Plasma pentraxin 3 levels do not predict coronary events but reflect metabolic disorders in patients with coronary artery disease in the CARE trial |
| Q55499529 | Pro-Inflammatory Biomarkers in Stable Versus Acutely Decompensated Heart Failure With Preserved Ejection Fraction. |
| Q35133148 | Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis |
| Q52761490 | Relationship between plasma pentraxin 3 level and risk of chronic kidney disease in the Korean elderly: the Dong-gu study. |
| Q51345186 | Relationship of pentraxin 3 with insulin sensitivity in gestational diabetes. |
| Q41741922 | Serum Pentraxin-3 Level in Patients Who Underwent Coronary Angiography and Relationship with Coronary Atherosclerosis |
| Q53394696 | Serum levels of pentraxin-3 and other inflammatory biomarkers in migraine: Association with migraine characteristics. |
| Q58565805 | Serum pentraxin-3 levels and flow-mediated dilation in dipper and non-dipper hypertension |
| Q42759835 | Serum pentraxin-3 levels are associated with the severity of metabolic syndrome |
| Q37234962 | Synergistic effects of hypertension and aging on cognitive function and hippocampal expression of genes involved in β-amyloid generation and Alzheimer's disease |
| Q37627769 | The acute-phase protein PTX3 is an essential mediator of glial scar formation and resolution of brain edema after ischemic injury |
| Q58794640 | The effect of group-based cognitive behavioral therapy on inflammatory biomarkers in patients with coronary heart disease—results from the SUPRIM-trial |
| Q40900237 | The effects of high intensity interval training in women with rheumatic disease: a pilot study |
| Q26738957 | The inflammatory protein Pentraxin 3 in cardiovascular disease |
| Q37851153 | The long pentraxin PTX3 at the crossroads between innate immunity and tissue remodelling |
| Q38102657 | The long pentraxin PTX3: a candidate anti-inflammatory mediator in cardiac surgery. |
| Q38092832 | The long pentraxin PTX3: a paradigm for humoral pattern recognition molecules |
| Q37668815 | The time profile of Pentraxin 3 in patients with acute ST-elevation myocardial infarction and stable angina pectoris undergoing percutaneous coronary intervention. |
| Q38209027 | The yin-yang of long pentraxin PTX3 in inflammation and immunity |
| Q47626900 | Update on the role of Pentraxin 3 in atherosclerosis and cardiovascular diseases |
| Q36869842 | Vascular pentraxin 3 controls arterial thrombosis by targeting collagen and fibrinogen induced platelets aggregation |
Search more.